(12-267) Characterizing the Use of Floxuridine (FUDR) Hepatic Arterial Infusion (HAI) Devices for the Treatment of Intrahepatic Cholangiocarcinoma and Metastatic Colorectal Cancer with Liver Metastases
Wednesday, December 10, 2025
2:00 PM - 3:00 PM
Location: Bayside A, Level 1
Residency Program: Allegheny General Hospital Residency Program Type: PGY2 (Oncology Pharmacy) Residency Program Location: Pennsylvania
